LG Chem Enters Final Stage of Clinical Development for New Gout Drug

3 years ago

SEOUL, South Korea & CAMBRIDGE, Mass.--(BUSINESS WIRE)--#Gout--LG Chem recently announced that the Company has submitted an IND application to the…

Hong Kong Smart Design, Sparkle in Greater Bay Area 2022; Hong Kong Creative Industries Summit: Energize Borderless Opportunities

3 years ago

Gear up! Capture the Opportunities amid the Pandemic and Tap into Greater Bay Area Market HONG KONG SAR - Media…

Thailand Connected Trucks Telematics Market Analysis/Opportunities Report 2022 – ResearchAndMarkets.com

3 years ago

DUBLIN--(BUSINESS WIRE)--The "Thailand Connected Trucks Telematics Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This research service analyzes the…

3 years ago

Research Evaluates Effects of Against the Tumor Microenvironment MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTCQB: PPCB) (�Propanc� or the �Company�), a…

3 years ago

SYDNEY, Australia--(BUSINESS WIRE)--#asx--Comprehensive cyber protection for SMBs has emerged as the next great revenue driver for IT service providers, with…

Rising Cost of Living Driving 1 in 2 Consumers to Cut Back on Spending, According to LoopMe Survey

3 years ago

Of nearly 18,000 consumers surveyed in U.S., U.K., and Australia, 67% do not want to work from the office, and…

3 years ago

HAWTHORNE, Calif.--(BUSINESS WIRE)--OSI Systems, Inc. (NASDAQ: OSIS) announces that its Chairman and Chief Executive Officer, Deepak Chopra, has been appointed…

Shape Memory Medical Celebrates Treatment of 1,500th Patient

3 years ago

SANTA CLARA, Calif.--(BUSINESS WIRE)--#ShapeMemoryPolymer--Shape Memory Medical Inc., developer of shape memory polymer devices for peripheral and neurovascular markets, announced today…

OliX Pharmaceuticals Receives IND Approval from FDA to Develop RNAi Therapeutic OLX10212 for Age-related Macular Degeneration

3 years ago

SUWON, South Korea--(BUSINESS WIRE)--#AgeRelatedMacularDegeneration--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the U.S. Food…

PharmaEssentia Appoints Dr. Lih-Ling Lin as Chief Scientific Officer

3 years ago

Dr. Lin, formerly of Sanofi, to lead expansion and acceleration of global R&D efforts BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia Corporation, (TPEx:6446), a…

Show more Posts
Show previous Posts